Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 15 patent families, including 27 granted patents and 24 pending applications. The portfolio spans a range of jurisdictions, including the United States, Europe, India, and China.
企業コードCMND
会社名Clearmind Medicine Inc
上場日Aug 10, 2021
最高経営責任者「CEO」Dr. Adi Zuloff-Shani
従業員数- -
証券種類Ordinary Share
決算期末Aug 10
本社所在地101-1220 West 6Th Avenue
都市VANCOUVER
証券取引所NASDAQ Capital Market Consolidated
国Canada
郵便番号V6H 1A5
電話番号16042601566
ウェブサイトhttps://www.clearmindmedicine.com/
企業コードCMND
上場日Aug 10, 2021
最高経営責任者「CEO」Dr. Adi Zuloff-Shani
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし